Altum Sequencing is a pioneering company dedicated to advancing clinical molecular diagnostics through innovative bioinformatics solutions. The organization focuses on developing, validating, and maintaining bioinformatics pipelines and data analysis workflows that comply with UNE-EN ISO 15189 standards, ensuring the accuracy and reliability of patient results. With a mission-driven approach, Altum Sequencing is at the forefront of cancer detection technologies, utilizing cutting-edge liquid biopsy and minimal residual disease (MRD) methodologies. The company fosters a collaborative culture, encouraging cross-functional teamwork among clinical, research and development, and product teams, while also providing flexible work arrangements and opportunities for continuous learning.